screening, COVID-19, hypertension, type 2 diabetes mellitus, linkage-to-care, South Africa
COVID-19, diagnostics, RDT, PCR, tocilizumab, corticosteroids, cost-effectiveness, low-and-middle income countries, low-resource contexts